Sickle Cell Anemia
DiscoveriesWorld’s first CRISPR gene-editing treatment just received regulatory approval
Casgevy is designed to address two debilitating blood disorders: sickle cell disease (SCD) and transfusion-dependent beta-thalassemia.
Joseph Shavit